20/20 Biolabs, Inc. (AIDX)
0.5139
-0.04
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
0.5139
0.00 (0.00%)
After-Hours: 20:00
20/20 Biolabs Total Liabilities (Quarterly) : 2.964M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.964M |
| March 31, 2026 | 3.046M |
| December 31, 2025 | 4.157M |
| September 30, 2025 | 3.131M |
| March 31, 2025 |
| Date | Value |
|---|---|
| December 31, 2024 | 2.079M |
| September 30, 2024 | |
| June 30, 2023 | 2.253M |
| March 31, 2023 | 2.618M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 61.21M |
| Intelligent Bio Solutions, Inc. | 6.991M |
| Anteris Technologies Global Corp. | 20.84M |
| Quest Diagnostics, Inc. | 9.04B |
| Labcorp Holdings, Inc. | 9.909B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.123M |
| Shareholders Equity (Quarterly) | 3.159M |
| Debt to Equity Ratio | 0.1812 |
| Current Ratio | 1.990 |
| Net Debt Paydown Yield | 0.79% |